Antinociception in rat by sarpogrelate, a selective 5-HT 2A receptor antagonist, is peripheral

By Obata H.   Saito S.   Ishizaki K.   Goto F.  

European Journal of Pharmacology, Vol. 404, Iss. 1, 2000-09 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

The corticosterone-enhancing effects of the 5-HT 1A receptor antagonist, (S)-UH301, are not mediated by the 5-HT 1A receptor

By Groenink L.   Van der Gugten J.   Mos J.   Maes R.A.A.   Oliver B.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction

By Galzin  

European Journal of Pharmacology, Vol. 404, Iss. 3, 2000-09 ,pp. : 361-368

Elsevier

Access to resources Recommend Favorite

Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist

By O'Connor S.E.   Grosset A.   Drieu La Rochelle C.   Gautier E.   Bidouard J.-P.   Robineau P.   Caille D.   Janiak P.  

European Journal of Pharmacology, Vol. 414, Iss. 2, 2001-03 ,pp. : 259-269

Elsevier

Access to resources Recommend Favorite

Antiemetic effects of N-3389, a newly synthesized 5-HT 3 and 5-HT 4 receptor antagonist, in ferrets

By Minami M.   Endo T.   Tamakai H.   Ogawa T.   Hamaue N.   Hirafuji M.   Monma Y.   Yoshioka M.   Hagihara K.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 333-342

Elsevier

Access to resources Recommend Favorite